Marking off new territory in the search for anticancer compounds: epigenetic mechanisms add complexity and promise to cancer research efforts.
作者信息
Nelson Bryn
出版信息
Cancer Cytopathol. 2012 Jun 25;120(3):143-4. doi: 10.1002/cncy.21212.
PMID:22692980
Abstract
摘要
相似文献
1
Marking off new territory in the search for anticancer compounds: epigenetic mechanisms add complexity and promise to cancer research efforts.在抗癌化合物的探索中开辟新领域：表观遗传机制为癌症研究增添了复杂性和希望。
Cancer Cytopathol. 2012 Jun 25;120(3):143-4. doi: 10.1002/cncy.21212.
2
Despite criticism of the FDA review process, new cancer drugs reach patients sooner in the United States than in Europe.尽管人们对 FDA 的审查程序提出了批评，但新的癌症药物在美国上市的速度比在欧洲更快。
Health Aff (Millwood). 2011 Jul;30(7):1375-81. doi: 10.1377/hlthaff.2011.0231. Epub 2011 Jun 16.
3
Can single-patient investigational new drug studies hurry slow trains to the fast track?单患者研究性新药研究能否让慢车加速驶入快车道？
Drug Discov Today. 2006 Mar;11(5-6):185-6. doi: 10.1016/S1359-6446(05)03707-4.
4
Cancer drugs. Weighing the risks and benefits.抗癌药物。权衡风险与益处。
FDA Consum. 2007 Jan-Feb;41(1):10-9.
5
An audience with Tatiana Prowell. Interviewed by Asher Mullard.对塔蒂亚娜·普罗韦尔的访谈。采访者：亚瑟·穆拉德。
Nat Rev Drug Discov. 2014 Jun;13(6):410-1. doi: 10.1038/nrd4335.
6
One community. The B. Chevalier Lecture, held at the EORTC New Drugs Meeting, Lugano, Switzerland, 19-21 June 1997.一个共同体。1997年6月19日至21日在瑞士卢加诺举行的欧洲癌症研究与治疗组织（EORTC）新药会议上的B. 谢瓦利埃讲座。
Ann Oncol. 1998 Mar;9(3):251-4. doi: 10.1023/a:1008207304355.
7
The era of cancer discovery.癌症发现的时代。
Cancer Discov. 2011 Jun;1(1):1. doi: 10.1158/2159-8274.CD-11-0049. Epub 2011 Jun 1.
8
[Off-label use in oncology. The Italian choice].[肿瘤学中的超说明书用药。意大利的选择]
Recenti Prog Med. 2008 Dec;99(12):612-5.
9
Slow start to phase 0 as researchers debate value.由于研究人员对价值存在争议，0期研究起步缓慢。
J Natl Cancer Inst. 2006 Jun 21;98(12):804-6. doi: 10.1093/jnci/djj249.
10
Regulatory watch: Why do oncology drugs fail to gain US regulatory approval?监管观察：肿瘤药物为何未能获得美国监管批准？
Nat Rev Drug Discov. 2015 Jul;14(7):450-1. doi: 10.1038/nrd4651. Epub 2015 May 22.
Zotero 插件